Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Objective: We aimed to evaluate the efficacy of canagliflozin for the treatment of specific cardiovascular and renal outcomes in Type 2 diabetes mellitus (T2DM) patients by means of a systematic review and meta-analysis. Methods: We performed comprehensive searches of PubMed, the Cochrane Library, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Lei, Cai, Yuzi, Zheng, Huijuan, Ai, Sinan, Zhou, Mengqi, Luo, Qian, Tang, Jingyi, Liu, Weijing, Wang, Yaoxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327383/
https://www.ncbi.nlm.nih.gov/pubmed/34349651
http://dx.doi.org/10.3389/fphar.2021.691878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327383/
https://www.ncbi.nlm.nih.gov/pubmed/34349651
http://dx.doi.org/10.3389/fphar.2021.691878

Ejemplares similares